Donor-Derived Cell-Free DNA as a Marker for the Efficacy of Daratumumab in Patients With Antibody-Mediated Rejection Post-Heart Transplantation: A Case Series
供体来源的游离DNA作为达雷妥尤单抗治疗心脏移植术后抗体介导排斥反应患者疗效的标志物:病例系列研究
期刊:Pediatric Transplantation
影响因子:1.4
doi:10.1111/petr.70168
Konduri, Anusha; Flynn, Kathryn E; Huebschman, Ashley; Crandall, Bronwyn; Sinicropi, Natalie; Giacobbe, Bethany; Zamberlan, Mary; Najor, Matthew; Cusick, Matthew; Lim, Heang M; McCormick, Amanda D; Schumacher, Kurt R; Peng, David M